Oric Pharmaceuticals Inc.

Oric Pharmaceuticals Inc.

World Rank (Aug-2026)
7628
Market Cap (Aug-2026)
1.438 Billion USD
Market Cap (Mar-08-2026)
1.376 Billion USD
World Rank (Jan-05-2024)
12,752
Market Cap (Jan-05-2024)
0.489 Billion USD
World Rank (Jul-30-2023)
14,604
Market Cap (Jul-30-2023)
0.372 Billion USD
World Rank (Jan-07-2022)
12,703
Market Cap (Jan-07-2022)
0.564 Billion USD
World Rank (Jan-01-2021)
7,203
Market Cap (Jan-01-2021)
1.205 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
ORIC
Employee Count
57
Employee Count as of Date
As on December-2020
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Operating Income in USD
-143 Million USD
Annual Net Income in USD
-129 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
409 Million USD
Total Liabilities in USD
25 Million USD
Total Equity in USD
384 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Biopharmaceutical
Company Website
ORIC PHARMACEUTICALS, INC.
Yahoo
Yahoo @ Nasdaq
Company Profile
ORIC Pharmaceuticals is a Clinical Stage Biopharmaceutical company focused on discovering and developing innovative therapies that benefit patients with cancer. The company annual revenue is 1.07 billion USD and 60 employees as on 2019. The headquarters is in USA.
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share